582 related articles for article (PubMed ID: 9436194)
1. In vivo antimetastatic action of ginseng protopanaxadiol saponins is based on their intestinal bacterial metabolites after oral administration.
Wakabayashi C; Hasegawa H; Murata J; Saiki I
Oncol Res; 1997; 9(8):411-7. PubMed ID: 9436194
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of in vitro tumor cell invasion by ginsenoside Rg3.
Shinkai K; Akedo H; Mukai M; Imamura F; Isoai A; Kobayashi M; Kitagawa I
Jpn J Cancer Res; 1996 Apr; 87(4):357-62. PubMed ID: 8641966
[TBL] [Abstract][Full Text] [Related]
3. Carvacrol as a Stimulant of the Expression of Key Genes of the Ginsenoside Biosynthesis Pathway and Its Effect on the Production of Ginseng Saponins in
Kochan E; Sienkiewicz M; Szmajda-Krygier D; Balcerczak E; Szymańska G
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255986
[TBL] [Abstract][Full Text] [Related]
4.
Zhang M; Wang Y; Wu Y; Li F; Han M; Dai Y; Zheng F; Yue H
Evid Based Complement Alternat Med; 2021; 2021():1735803. PubMed ID: 34721619
[TBL] [Abstract][Full Text] [Related]
5. Screening of plants from the Brazilian Atlantic Forest led to the identification of Athenaea velutina (Solanaceae) as a novel source of antimetastatic agents.
Almeida AA; Lima GDA; Simão MVRC; Moreira GA; Siqueira RP; Zanatta AC; Vilegas W; Machado-Neves M; Bressan GC; Leite JPV
Int J Exp Pathol; 2020 Jun; 101(3-4):106-121. PubMed ID: 32452573
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of tumor-induced angiogenesis by a synthetic lipid A analogue with low endotoxicity, DT-5461.
Sato K; Yoo YC; Mochizuki M; Saiki I; Takahashi TA; Azuma I
Jpn J Cancer Res; 1995 Apr; 86(4):374-82. PubMed ID: 7539783
[TBL] [Abstract][Full Text] [Related]
7. Significant difference in active metabolite levels of ginseng in humans consuming Asian or Western diet: The link with enteric microbiota.
Wan JY; Wang CZ; Zhang QH; Liu Z; Musch MW; Bissonnette M; Chang EB; Li P; Qi LW; Yuan CS
Biomed Chromatogr; 2017 Apr; 31(4):. PubMed ID: 27606833
[TBL] [Abstract][Full Text] [Related]
8. Biotransformation approach to produce rare ginsenosides F1, compound Mc1, and Rd2 from major ginsenosides.
Diao M; Chen Y; Meng L; Li J; Xie N
Arch Microbiol; 2024 Mar; 206(4):176. PubMed ID: 38493413
[TBL] [Abstract][Full Text] [Related]
9. Antimetastatic activity of polymeric RGDT peptides conjugated with poly(ethylene glycol).
Saiki I; Yoneda J; Igarashi Y; Aoki M; Kusunose N; Ono K; Azuma I
Jpn J Cancer Res; 1993 May; 84(5):558-65. PubMed ID: 8320173
[TBL] [Abstract][Full Text] [Related]
10. Anti-
Yan W; Cui Z; Li W; An X; Cheng X; Wang S; Jin C
Pharmazie; 2023 Dec; 78(11):225-230. PubMed ID: 38178283
[TBL] [Abstract][Full Text] [Related]
11. Discovery of a septin-4 covalent binder with antimetastatic activity in a mouse model of melanoma.
Blua F; Monge C; Gastaldi S; Clemente N; Pizzimenti S; Lazzarato L; Senetta R; Vittorio S; Gigliotti CL; Boggio E; Dianzani U; Vistoli G; Altomare AA; Aldini G; Dianzani C; Marini E; Bertinaria M
Bioorg Chem; 2024 Mar; 144():107164. PubMed ID: 38306824
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of bestatin and oral activity for treatment of experimental metastases.
Abe F; Alvord G; Koyama M; Matsuda A; Talmadge JE
Cancer Immunol Immunother; 1989; 28(1):29-33. PubMed ID: 2909281
[TBL] [Abstract][Full Text] [Related]
13. The anti-aging mechanism of ginsenosides with medicine and food homology.
Tian T; Ko CN; Luo W; Li D; Yang C
Food Funct; 2023 Oct; 14(20):9123-9136. PubMed ID: 37766674
[TBL] [Abstract][Full Text] [Related]
14. Preclinical studies with prothymosin alpha1 on mononuclear cells from tumor patients.
Eckert K; Grünberg E; Garbin F; Maurer HR
Int J Immunopharmacol; 1997; 19(9-10):493-500. PubMed ID: 9637344
[TBL] [Abstract][Full Text] [Related]
15. Higher frequency of selective losses of HLA-A and -B allospecificities in metastasis than in primary melanoma lesions.
Geertsen RC; Hofbauer GF; Yue FY; Manolio S; Burg G; Dummer R
J Invest Dermatol; 1998 Sep; 111(3):497-502. PubMed ID: 9740247
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase inhibitors up-regulate the expression of cell surface MHC class-I molecules in B16/BL6 cells.
Komatsu Y; Hayashi H
J Antibiot (Tokyo); 1998 Jan; 51(1):89-91. PubMed ID: 9531994
[No Abstract] [Full Text] [Related]
17. Cardiac metastases from malignant melanoma.
Gibbs P; Cebon JS; Calafiore P; Robinson WA
Cancer; 1999 Jan; 85(1):78-84. PubMed ID: 9921977
[TBL] [Abstract][Full Text] [Related]
18. A big gene linked to small eyes encodes multiple Mitf isoforms: many promoters make light work.
Yasumoto K; Amae S; Udono T; Fuse N; Takeda K; Shibahara S
Pigment Cell Res; 1998 Dec; 11(6):329-36. PubMed ID: 9870544
[TBL] [Abstract][Full Text] [Related]
19. Expression of the insulin-like growth factor-1 receptor and its anti-apoptotic effect in malignant melanoma: a potential therapeutic target.
Kanter-Lewensohn L; Dricu A; Wang M; Wejde J; Kiessling R; Larsson O
Melanoma Res; 1998 Oct; 8(5):389-97. PubMed ID: 9835451
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic markers, sunlight-related factors and sunscreen use in patients with cutaneous melanoma: an Austrian case-control study.
Wolf P; Quehenberger F; Müllegger R; Stranz B; Kerl H
Melanoma Res; 1998 Aug; 8(4):370-8. PubMed ID: 9764814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
